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Veronica C. Karpiak, M.S., 1998 Pharmacology
CHARACTERIZATION OF ORGANOTIN TOXICITY IN PRIMARY ASTROCYTE
CULTURES (pp. 58)
Director: Charles L. Eyer, Ph.D.
Thesis Abstract
Increased worldwide use of organotins has raised concerns about ecological
contamination and health risks. Organotins produce a range of toxicological effects
including damage to several organ systems in mammals and humans. Several of these
compounds produce serious deficits in the central nervous system. Our investigation
characterized organotin toxicity in a rat astrocyte model. Time and concentration effects
o f trimethyltin (TMT), triethyltin (TET), tributyltin (TBT), and triphenyltin (TPT) were
determined by measuring lactate dehydrogenase (LDH) release, 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tétrazolium bromide (MTT) reduction to formazan, and observing
morphological changes. Established subtoxic concentrations of TMT and TET, two
neurotoxic organotins, and TPT, a non-neurotoxic organotin, were used to investigate the
effects of organotins on astrocytic glutamate homeostasis.
Cytotoxicity studies showed a relative order of potency of TPT>TBT, TE1>TMT. This
order is similar to that reported in other cell types. TMT required higher concentrations
and longer exposure times to produce the same toxicity observed after exposure of
astrocytes to the other organotins. Observed morphological changes correlated with
cytotoxicity results. Data from the MTT assay showed that 10 pM TMT and TET
produced an initial increase in metabolic activity, which in the case of TMT occurred
prior to the onset of cytotoxicity. The same concentration of TBT and TPT did not cause
this increase.
We investigated the effects of subtoxic concentrations of organotins on glutamine
synthetase (OS) and glutamate transport, two key components of glutamate homeostasis
in astrocytes. TMT, TET, and TPT decreased OS activity. Only TET decreased both OS
and glutamate transport activity. The time and concentration response of cytotoxicity and
changes in astrocytic glutamate homeostasis found in our study do not correlate with in
vivo pathology, but may account for regional CNS specificity after organotin exposure.
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Introduction
Organotins
Organotins are synthetic compounds many of which produce distinct toxicity to a
variety of living species including man (Barnes and Stoner, 1959). The mono-, di-, tri-,
or tetra- substituted organotins have widespread use in the chemical, agriculture, wood
products and shipping industries (Boyer, 1989). As of the mid-1980’s, 50,000 tons of
organotins were produced annually. Studies of environmental impact show
biomethylation of inorganic tin, bioaccumulation in heavily shipped waterways, and
bioconcentration of organotins in shellfish and bottom feeders (Clarkson et al, 1987).
Trimethyltin (TMT) and triethyltin (TET) are both neurotoxic and are used in agriculture
and the plastics industry (McMillan and Wenger, 1985). Tributyltin (TBT) and
triphenyltin (TPT) are both used in the shipping industry in anti-fouling paint and have
been shown to contaminate large shipping harbors (Morcillo et a l, 1997).
Triorganotins have been shown to be the most potent organotin toxicants in
mammals (Boyer, 1989; McMillan and Wenger, 1985). Symptoms of triorganotin
exposure include aggression and memory loss (TMT), cerebral edema (TET), dermal
irritation (TBT), and hepatic and biliary inflammation (TBT, TPT). Increasing alkyl
chain length and lipophilicity alter the specific toxic effects of triorganotins. TET shows
the highest mammalian toxicity, TBT and TPT show highest activity against fungi, and
TMT against insects (Nicklin and Robson, 1988).
Both TBT and TPT cause immunotoxic thymic damage. Exposure of these
compounds also leads to renal and hepatic damage (Nicklin and Robson, 1988). Even
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though no in vivo CNS pathology of TBT or TPT has been found (Bouidin et al, 1981),
TPT has been shown to accumulate in brain tissue (Heath, 1963). Both TBT and TPT
have been implicated in disruption of intracellular calcium movement and apoptotic cell
death in neuronal type P C I2 cells (Viviani, et a i, 1995). TBT has been found to interact
with cytochrome P450-1A metabolism (DeLong and Rice, 1997) and to decrease
norepinephrine levels in the CNS (Boyer, 1989) after in vivo exposure. Although TPT is
not known as a neurotoxicant, a case study of TPT exposure has described CNS
symptoms including severe ataxia, blurring of vision, disturbance of consciousness and
confusion (Wu et a l, 1990).
Distribution studies of TMT and TET show widespread CNS accumulation of
both organotins with differences in elimination rates (Cook et al, 1984). In these studies
the half life in brain tissue for TMT was reported as 10.2 days and 4.6 days for TET.
Both TET and TMT alter oxidative phosphorylation and disrupt Na^ -K^ -ATPases
(Aldridge and Street, 1971). TET causes demyelination and cerebral edema with some
seizure activity (Kimbrough, 1976). TMT causes specific pathology in the limbic system
o f the CNS with neuronal loss in the hippocampal CA region (Chang, 1986). Symptoms
o f TMT exposure include behavioral changes, seizures, and memory loss (Brown et a l,
1979; Dyer et a l, 1982). It is unclear why TMT neurotoxicity exhibits such regional
specificity and whether the primary insult occurs to glia or neurons.

G lutam ate Activity in the H ippocam pus
In addition to being a target of TMT toxicity, the hippocampus and related limbic
structures have been shown to be vulnerable in several neurological insults, including
hypoglycemia, anoxia, ischemia and epilepsy (Cotman et al., 1989). Glutamate is the
primary excitatory amino acid (EAA) neurotransmitter in the mammalian nervous system
with a high concentration of receptors in the limbic region (Monaghan et al, 1989).
Elevated levels of glutamate can cause neuronal damage known as excitotoxicity
(Rothman and Olney, 1989). Over-activation of EAA receptors results in a disruption of
N a \ Cl", and C a^ flux that can produce osmotic imbalances and cell swelling. Increased
intracellular levels of calcium can lead to increased activity of potentially destructive
enzymes such as lipases, proteases and oxidases. Because of the dual nature of glutamate
as a neurotransmitter and potential toxin, levels must be closely regulated in the CNS
(Bridges and Cotman, 1991).

Astrocyte Regulation of G lutam ate
The astrocyte plays a role in the maintenance o f glutamate homeostasis in the
CNS (Norenberg and Martinez-Hemandez, 1979). Extracellular glutamate levels are
decreased by rapid Na^^-dependent astrocytic glutamate uptalce. Once inside the cell,
glutamate is converted to glutamine by the astrocyte specific enzyme glutamine
synthetase (GS) (EC 6 .3.1.2) (Farinelli and Nicklas, 1992). The non-excitotoxic
glutamine is then transported back to the neuron and reconverted to glutamate by
neuronal glutaminase (EC 3.5.1.2). A decrease in the ability o f the astrocyte to maintain

this glutamate flux can contribute to elevated levels of glutamate in the synapse,
potentially facilitating excitotoxic injury (Takahashi et al, 1997).
TMT has been shown to interact with several neurotransmitters including the
glutamatergic system (Earley et al, 1992). TMT increases glutamate release in
hippocampal slices (Patel et al, 1990) and cortical slices (Dawson et al, 1995) as well as
decreasing glutamate uptake (Aschner et al, 1992). In vivo TMT exposure has also been
shown to increase levels of the astrocytic marker glial fibrillary acidic protein (GFAP)
(Brock and O'Callaghan, 1987). TMT effects on specific astrocyte functions related to
glutamate homeostasis are unknown. A more detailed investigation of the effect of
organotins on astrocytic glutamate homeostasis is needed.
The purpose of this investigation is to define the relative toxicity of organotins in
primary astrocyte culture and explore the possible interaction of these compounds with
glutamate homeostasis in astrocytes. Time and concentration effects of organotins will
be determined in primary astrocyte cultures. An established subtoxic concentration will
be used to define effects of organotins on astrocytic GS and glutamate transport.

Chapter 1: Differential Cytotoxicity of Four Organotins in Primary Astrocyte
Cultures
Abstract
The role of astrocytes in organotin toxicity was investigated by comparing the
cytotoxicity o f trimethyltin (TMT), triethyltin (TET), tributyltin (TBT), and triphenyltin
(TPT) in rat cortical astrocyte cultures. Time and concentration effects of the organotins
were determined by measuring lactate dehydrogenase (LDH) (EC 1.1.1.27) release, 3(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tétrazolium bromide (MTT) reduction, and by
observing morphological changes. TET, TBT, and TPT produced cytotoxicity after 24 hr
exposure to a concentration as low as 2.5 pM. One hundred micromolar TMT did not
produce toxicity until 48 hr after exposure. Observed morphological changes after 10
pM organotin exposure for 24 hr paralleled the increases in extracellular LDH. Twentyfour hour exposure to 10 pM TMT increased MTT reduction to formazan without
affecting LDH release. In contrast, TET exposure increased formazan production while
decreasing cell viability measured by LDH release. TBT and TPT decreased formazan
production and increased LDH release. The increase in MTT reduction after TMT and
TET exposure suggests a burst of mitochondrial activity prior to cell death. The four
organotins exhibited marked differences in relative potency and the time required for
development of cytotoxicity in astrocyte cultures. TMT required both higher
concentrations and more time to produce toxicity than the other three organotins. The
relative toxicity of TMT, TET, TBT, and TPT in astrocyte cultures does not reflect the in
vivo specificity of these organotins in the CNS.
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Introduction
Organotins are widely used in industry and agriculture as plastic stabilizers,
molluscicides, insecticides, and fungicides (Nicklin and Robson, 1988). Triethyltin
(TET) and trimethyltin (TMT) are known to cause damage in the central nervous system
(CNS). TET is a demyelinating agent which causes edema and swelling within the CNS
(Kimbrough, 1976). TMT primarily affects the hippocampus causing pyramidal cell loss
(Chang, 1986). The higher molecular weight organotins such as tributyltin (TBT), and
triphenyltin (TPT) are known to be immunotoxic, disrupting thymocyte and lymphocyte
function as well as causing renal and hepatic damage (Snoeij et al., 1987). Some
reversible nervous system damage has been seen in case studies of acute TPT exposure
(Wu et al., 1990).
Astrocytes play a supportive and interactive role with neurons in maintaining
ionic and chemical homeostasis (Vemadakis, 1996; Silver et a l, 1997). These cells have
been implicated in injury and diseases such as amyotrophic lateral sclerosis (ALS) and
ischemia (Walum et a l, 1995). Several studies have linked TMT neurotoxicity to
astrocytes. Aschner and Aschner (1992) suggest that astrocytes may represent an
important link in the CNS damage produced by TMT because of evidence of prominently
swollen astrocytes without neuronal involvement after in vivo exposure. In vivo exposure
to TMT also produces a transient astrocytic response seen by an increase in the specific
cell marker glial fibrillary acidic protein (GFAP) (Brock and O'Callaghan, 1987).
In order to better understand the role of astrocytes in TMT neurotoxicity our
laboratory has investigated the comparative toxicity of organotins in cortical astrocyte

7

cell cultures. No neurotoxicity has been documented after in vivo exposure to TBT or
TPT (Nicklin and Robson, 1988). TET is known to target myelin producing ceils which
should not be present in primary astrocyte cultures. If astrocytes play a key role in TMTinduced neurotoxicity then this organotin should show some unique feature not seen with
organotins exhibiting different toxic specificity.
In our astrocyte cell culture system, TMT produced a delayed cytotoxicity
confirmed by LDH release and photomicrographs. After 24 hr exposure, 2.5 pM and
greater concentrations of the other organotins produced cytotoxicity, paralleled by
observable morphological change. MTT studies showed an initial increase in
mitochondrial activity after TMT and TET exposure. This increase was followed by a
decrease at 72 hr. TBT and TPT exposure decreased mitochondrial activity at all time
points.

Methods

Materials:
Pregnant female Sprague-Dawley rats were obtained from Simonsen Labs
(Gilroy, CA). Rats were maintained on a 12 hr light-dark cycle with food and water ad
libitum. Cell culture media was purchased from Gibco-BRL (Grand Island, NY) and
fetal calf serum (PCS) from Hyclone (Logan, UT). All cell culture plasticware was
obtained from Fisher Scientific (Santa Clara, CA). All chemicals were purchased from
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Sigma (St. Louis, MO), except trimethyltin chloride, triethyltin chloride, tributlytin
chloride, and triphenyltin chloride (Aldrich, Milwaukee, WI)

Cell Culture:
Primary cultures o f type I astrocytes were prepared from 4 day old rat pups as
described by McCarthy and de Vellis (1980). Cortical hemispheres were dissected free
and the meninges and subcortical structures removed. After disruption of the cortical
tissue by trituration, the cells were plated in a 1:1 mixture of Dulbecco’s Modification of
Eagle’s Medium and Ham’s F I2 medium. Media was supplemented by addition of 15
mM HEPES and 1.2 g/L of sodium bicarbonate, penicillin (100 units/ml), streptomycin
(100 pg/ml), and Fungizone (0.1 pg/ml). The pH was adjusted to 7.4. The cells were
cultured in poly-D-lysine coated 80 cm^ flasks maintained at 37° C in a humid
atmosphere containing 5% COj. The medium was supplemented with 15% FCS during
the initial plating and then maintained with 10% FCS.
When 60-70% confluent, the cells were shaken in fresh media on a Hi-Line orbital
shaker (280 RPM, 24 hr) to remove oligodendrocytes, type II astrocytes, and microglia.
Three days later the astrocytes were harvested by trypsinization and plated into uncoated
Falcon 12 well plates at a density of 10^ cells/ml. These secondary cultures were
maintained in a similar environment with media changes every 3-4 days and allowed to
reach confluence (14-21 days). Homogeneity of astrocyte cultures was monitored by
microscopic observation and by the presence of the astrocytic marker GFAP. Cultures
were found to be > 95% GFAP (+).
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Cells were viewed and morphological changes documented by photomicrographs
on an Olympus Inverted Research Microscope, Model IMT-2.

Organotin Treatments:
TMT, TET, and TBT were dissolved in distilled, deionized H^O, filter sterilized,
and introduced into the media to achieve the appropriate concentrations. TPT was
dissolved in 100% DMSG, diluted into media, sterile filtered and further diluted in media
to appropriate concentrations. DMSG did not exceed 0.1% in final dilution, a
concentration which did not change LDH release or formazan production in control
experiments.

Lactate Dehydrogenase (LDH):
Cell death was estimated by measuring the extent of lactate dehydrogenase (LDH)
leakage into the culture medium (Vassault, 1983; Koh and Choi, 1987). Extracellular
fluid was aspirated and cells were lysed with 0.1% Triton-X in serum-free culture media.
LDH activity was determined in the media and the cell lysate fraction by measuring the
rate of disappearance of NADH from the reaction mixture (AGD3 4 0 ) using a Molecular
Devices 96 well plate reader and SGFTmax PRG software. Percent extracellular LDH
was calculated using the formula: % extracellular LDH - 100 x [(extracellular
AGD/min) 4 - (extracellular + intracellular AGD/min)].
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M TT Reduction:
A second cell viability method was used to measure the reduction of a water
soluble tétrazolium salt (MTT) to formazan (Slater, 1963; Mossman, 1983). Briefly, 3(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tétrazolium bromide (MTT) was dissolved in
distilled, deionized H2 O at 5 mg/ml and further diluted to a 1:10 working solution in
Kreb’s Ringer Buffer (KRB). Extracellular media was aspirated from 12 well plates. A
volume of 200 pi of the MTT working solution, and 300 pi of KRB was added to each
well. Cells were incubated for 3 hr at 3 7*^ C. After 3 hr, 1.5 ml of 0.1 M HCl in
isopropanol was added to the wells to solubilize the purple formazan crystals. Sealed
well-plates were refrigerated overnight, and read on a Beckman DU450
spectrophotometer at 560 nm. Results were reported as a percent of the optical density
produced by control wells from the same culture plate.
The optical density values produced in the MTT assay are directly proportional to
mitochondrial activity and reflect cell viability rather than cell death (Mosmann, 1983).
In experiments comparing the values obtained in the two assays (LDH and MTT) LDH
data was expressed as percent intracellular LDH. This normalized the results of the two
assays with

1 0 0

% representing no cell death, making it possible to compare values from

both assays on the same set o f axes.

Il

Statistics:
The LDH and MTT experiments were repeated in different culture preparations
with n =

6

to 26 for each concentration and time point. Descriptive statistics, unpaired t

tests, ANOVA and Tukey’s multiple comparison test were determined using the
GBSTAT® software program.

Results
Figure 1 shows the time and concentration dependence o f astrocyte cytotoxicity
measured by LDH release. After 24 hr (Fig. 1A) exposure, differences in the time and
concentration effects of cytotoxicity can be observed. Concentrations of TPT (2.5 |iM
and greater) produced almost complete cell death. TET and TBT produced similar doseresponse curves with discernible cytotoxicity occurring at concentrations of 2.5 pM and
greater. TMT failed to produce any cytotoxicity at concentrations up to 100 pM.
After 48 hr (Fig. IB) exposure to TBT and TET concentrations of 2.5 pM and
greater produced significant increases in LDH release. Almost complete cell death
occurred at 10 pM and greater concentrations. TMT cytotoxicity only occurred following
100 pM exposure.
Increased cytotoxicity was evident after 72 hr exposure to the organotins (Fig.
1C). A slight increase in LDH release was produced by 1 pM TPT. No other organotin
produced observable cytotoxicity at this lowest concentration, but TET and TBT showed
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further increases in LDH release at the 2.5 and 5 pM concentrations. Concentrations of
TMT less than 10 |iM did not produce any significant increase in LDH release. Figure 1
shows that TMT was the least potent organotin used in these studies, and moreover TMT
toxicity was not detectable until after 24 hours.
The differences in morphological changes between TMT and the other organotins
correlated with differences in LDH release observed after 24 hr exposure. Figure 2 shows
a morphological comparison of 10 jaM organotin exposure for 24 hr in primary astrocyte
cultures. Control cells are shown in Fig. 2A. TMT (Fig. 2B) exposure did not cause an
observable morphological change. After 24 hr, the other organotins (TET, TBT and TPT)
had produced significant LDH leakage and visible morphological changes (Fig. 2C,D,E)
including cell shrinkage with elongated processes, nuclear prominence, and holes in the
monolayer of cells.
After 72 hr exposure, TMT (Fig. 3) still showed different morphological changes
from those seen after 24 hr exposure to TET, TBT, and TPT (Fig. 2). The astrocytes
shown in Figure 3 were noticeably larger and swollen in comparison to control cells with
vacuole formation. Following a 72 hr exposure to 10 pM TET, TBT, and TPT cells were
no longer present in the culture wells.
The MTT reduction assay was used as a second cell viability assay. Figure 4 is a
comparison of cell viability measured by intracellular LDH and MTT reduction. Figure
4A shows that 24 hr after exposure to 10 pM TMT and 10 pM TET a significant increase
in formazan production occurred. The percentage of viable cells measured by LDH was
not affected by TMT exposure. TET produced a significant decrease in cell viability.
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TBT produced a comparable reduction in both assays. TPT caused a significant decrease
in reduction capabilities of the astrocytes (MTT assay) with less than 3% of control levels
of formazan produced compared to 32 ± 3.2% intracellular LDH. After 48 and 72 hr
exposure to TBT and TPT reduced formazan production to less than 5% o f control (Fig.
4B, C). Figure 4B shows that after TET exposure for 48 hr, only 12% of the remaining
cells were viable. This decreased population of cells produced 90% of control levels of
formazan. After 72 hr exposure to 10 pM concentrations, all the organotins showed a
loss of cell viability in both the MTT and the LDH assays (Fig. 4C).
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Figure 1: Primary astrocytes were exposed to 1-100 pM concentrations of trimethyltin
(TMT), triethyltin (TET), tributyltin (TBT), or triphenyltin (TPT) and percent (%)
extracellular LDH was determined. Each data point represents n = 6 to 26. (A) 24 hr
organotin exposure, (B) 48 hr organotin exposure, (C) 72 hr organotin exposure. * =
lowest organotin concentration shown with a significant increase in LDH release (p <
0.01). Higher concentrations also produced significant increases in extracellular LDH.
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Figure l: Primary astrocytes were exposed to 1-100
concentrations of trimethyltin
(TMT), triethyltin (TET), tributyltin (TBT), or triphenyltin (TPT) and percent (%)
extracellular LDH was determined. Each data point represents n = 6 to 26. (A) 24 hr
organotin exposure, (B) 48 hr organotin exposure, (C) 72 hr organotin exposure. * lowest organotin concentration shown with a significant increase in LDH release (p <
0.01). Higher concentrations also produced significant increases in extracellular LDH.
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Figure 1: Primary astrocytes were exposed to 1 - 1 0 0
concentrations of trimethyltin
(TMT), triethyltin (TET), tributyltin (TBT), or triphenyltin (TPT) and percent (%)
extracellular LDH was determined. Each data point represents n = 6 to 26. (A) 24 hr
organotin exposure, (B) 48 hr organotin exposure, (C) 72 hr organotin exposure. * =
lowest organotin concentration shown with a significant increase in LDH release (p <
0.01). Higher concentrations also produced significant increases in extracellular LDH.
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Figure 2: Photomicrographs of
astrocytes exposed to 10 |aM
organotins for 24 hr. (A) control cells;
a flat mono-layer of polygonal cells,
(B) TMT : some spacing between cell
bodies, but mostly flat mono-layer of
cells, (C) TET : nuclear prominance
with elongated processes extending
between holes in mono-layer, (D)
TBT: cell shrinkage with nuclear
prominance, extended processes and
holes between cell bodies, (E) TFT :
cell shrinkage with extended processes
and gaping holes between cell bodies.
Bar = 30 pm.
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&

Figure 3: Astrocytes were exposed to 10 pM TMT for 72 hr. Cells appear large,
rounded and swollen with some process extension, vacuole formation, and holes in the
mono-layer. Control cells were still identical to those shown in Fig. 2A after 72 hr. Bar
30 \ i m .
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Figure 4 : Cells were exposed to 10 pM TMT, TET, TBT or TPT. The Y-axis represents
percent (%) intracellular LDH in LDH experiments and % control of formazan production
in MTT experiments. (A) 24 hr exposure, (B) 48 hr exposure, (C) 72 hr exposure.
Significant diiferences between LDH and MTT values were determined by the unpaired
Student’s t test, (n = 6 to 26, **p < 0.01)
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Discussion
The order of organotin effectiveness producing cytotoxicity in our astrocyte
cultures was found to be TPT>TBT, TET>TMT. TET is known to produce neurotoxicity
by causing changes in myelination, but not by affecting astrocyte function (Aschner and
Aschner, 1992). TBT and TPT are known to be immunotoxic (Nicklin and Robson,
1988), but gliotoxicity has not been reported. In our study higher concentrations and
longer periods o f time were required to produce cytotoxicity with TMT than with any of
the other three organotins. Exposure of thymocyte cultures to organotins produces the
same relative order of cytotoxicity (TPT>TBT>TET>TMT) after 10 to 30 hr exposure to
concentrations of 0.1-10 pM (Snoeij et a l, 1986). Thompson, et al. ( 1996) have
compared organotin toxicity in immortal cell lines (neuroblastomas, b-cell lines, NIH3T3 fibroblast and TC-7 kidney cells) and primary cells. They found the immortal cell
lines more sensitive to TBT and TET, but resistant to TMT. Primary neuronal and mixed
glial cultures exhibited the same order of sensitivity with TC 5 0 concentrations between
0.01 pM and 5 pM. The concentration range of organotin toxicity in primary astrocytes
(Fig. 1 ) correlates with the previous studies. It appears that the time and concentration
effect of organotin cytotoxicity that we observed in cultures of primary cortical astrocytes
correlates with that reported by others in isolated cell cultures. However, RichterLandsberg and Besser (1994), using the neutral red cytotoxicity assay, found a halfmaximal concentration of TMT at 2.5 pM. The above studies also used slightly different
cell culture preparations with a

1 0

% CO 2 environment and organotin treatments after

astrocytes were 4-5 weeks in vitro. The differences between effective toxic TMT
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concentrations could be explained by differences in how cytotoxicity was measured and
culture conditions.
The photomicrographs in Fig. 2 and 3 also show different time and concentration
effects of cell damage after TMT exposure. Apoptotic cell death, determined by DNA
fragmentation, has been implicated 24 hr after IpM or 2.5 pM TPT or 2.5 pM TBT
exposure for 30 min in PC 12 cells (Viviani et al^ 1995). The apoptotic cell death
described above accompanies LDH release. It is possible that the differences in
morphology we have observed are because of apoptotic cell death in astrocytes exposed
to TBT or TPT. Even after 72 hr, increased cell swelling after TMT exposure implies a
loss of osmotic control that was not seen with the other organotins. This osmotic effect
has been observed by others and is thought to be related to inhibition of astrocytic Na^ - ATPase (Aschner and Aschner, 1992).
The reduction of MTT to formazan is thought to occur in the mitochondria.
However, more recent investigations have suggested that the MTT assay is an indicator of
overall cell reductive capability (Liu et al., 1997) and not limited to mitochondrial
reductases. The increase in formazan production seen after 10 pM TMT exposure
suggests an increase in cell metabolic activity that precedes the cytotoxicity observed
with the LDH assay. After 24 hr exposure to 10 pM TET, astrocytes maintained 100% of
control levels of formazan production with an 80% reduction of cell population (Fig. 3A).
This same concentration of TMT and TET produced a significant decline in formazan
production after 72 hr. The increase in MTT reduction after 24 hr exposure to TMT and
TET followed by a decrease at later times suggests a burst of mitochondrial or metabolic
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activity in cells that later go on to die. In related studies, this same increase in formazan
production was seen in cell cultures derived from nitrosoethylurea-induced brain tumors,
after exposure to the mitochondrial protonophore uncoupler, carbonyl cyanide p~
trifluoromethoxyphenylhydrazone (FCCP) (Liu et al., 1997). TMT and TET have been
shown to inhibit oxidative phosphorylation (Aldridge and Street, 1971), disrupt the
hydroxyl-chloride gradient, and inhibit ATP synthesis (Aldridge, 1976) all of which
would compromise cellular energy metabolism. Since FCCP is a known protonophore
uncoupler that increases MTT reduction (Liu et al., 1997), uncoupling of oxidative
phosphorylation or disruption of cellular energy metabolism after exposure to TMT or
TET could account for the patterns of formazan production we observed in MTT
reduction.
The neurotoxic organotins appear to have some similar mechanisms of action
distinct from TBT and TPT. The MTT results after TMT and TET exposure suggest an
increase in metabolic activity in the astrocytes. Over time this increase may lead to
production of endogenous cytotoxic elements such as reactive oxygen species, or to
release of intracellular stores o f calcium. TBT and TPT have been shown to rapidly
increase intracellular calcium levels by increasing transmembrane movement and
promoting release from intracellular stores (Corsini et al, 1997; Viviani et al, 1995;
Zazueta et a/., 1994). The study by Viviani et al (1995) also reported that TET has a
minimal effect on calcium movement and TMT has no effect at all. The ability of TBT
and TPT to rapidly elevate intracellular calcium suggests a different mechanism of action
between the smaller, neurotoxic alkyl tins, and the larger, non-neurotoxic compounds.

25

The delayed cytotoxicity shown by TMT in the LDH studies and differences in
morphological changes between TMT and TET suggest differing mechanisms o f toxicity.
Concentrations as high as 100 pM TMT did not produce measurable cytotoxicity until 48
hr exposure. This initial TMT cytotoxicity occurred 24 hr after a 2.5pM concentration of
TET produced LDH leakage. While both compounds altered mitochondrial activity in
our studies, TMT caused less cell damage. A minor disruption in cellular energy
metabolism could account for the delay in measurable TMT cytotoxicity. The results
from the LDH and MTT experiments indicate that both TMT and TET can alter cell
metabolism prior to cell death, while TET rapidly disrupts the cell membrane.
The cytotoxicity observed in astrocyte cultures does not appear to reflect the
tissue specificity seen after in vivo organotin exposure. Concentrations of lOmg/kg of
TBT and 30 mg/kg of TPT do not produce CNS pathology in rat studies (Boyer, 1989).
In vivo distribution studies have detected TPT in CNS tissue up to 38 days after
administration (Heath, 1963). TPT has also been shown to increase the peak amplitude
and prolong the decay phase of sodium currents, and decrease the delayed outward
potassium currents in hippocampal pyramidal neurons (Oyama and Akaike, 1990). A
human case study (Wu, Chang, and Chiu, 1990) implicated TPT as causing reversible
neurological symptoms such as ataxia, confusion and visual disturbances. Reduction of
CNS norepinephrine levels has been observed after in vivo TBT exposure (Boyer, 1989)
indicating CNS involvement, but there were no neuropathological consequences from
exposure. It is well documented that TET and TMT enter the CNS (Cook, Stine and
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Reiter, 1984), although regional distribution is not correlated with region specific
pathology.
Another consideration of the in vivo environment is the presence of other glial
cells in the CNS. Although an in vivo astrocytic response to TMT is well documented,
purified cultures o f astrocytes may lack other neural cell types that could contribute to
toxicity. Oligodendrocytes and microglia could play a role in preventing the cellular
toxicity seen after TET, TBT, and TPT exposure in isolated astrocyte cultures. These
glial cells could also respond to TMT exposure by inducing cellular damage that could
not be detected in our cell culture model. Microglia are known to secrete both
neurotrophic and neurotoxic factors (Streit, 1996). TMT has been shown to cause an
increase in number and/or clustering of microglia at very low concentrations (10 ’®M to
1O'* M) in aggregating cell cultures, but responses are inconsistent at higher
concentrations (> 10'^ M) (Monnet-Tschudi et al., 1995). Streit (1996) has shown that 8
mg/kg o f TMT in rabbits induced microglial activation preceding astrogliosis. A
concentration o f 8 mg/kg of TMT has also been implicated in elevation of inflammatory
cytokine mRNA in rats. An astrocyte response marked by increased GFAP staining
followed 2-4 days after exposure (Maier et al, 1995).
In conclusion, the four organotins displayed significant differences in relative
potency and time of development of toxicity in astrocyte cultures. The non-neurotoxic
organotins TBT and TPT produced a rapid cytotoxicity in astrocyte cultures as shown by
LDH release, morphological changes and MTT reduction. We also observed early
increases in cell metabolic activity after TMT and TET exposure, followed by
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cytotoxicity. The order of effectiveness observed in the primary astrocyte cultures was
found to be TPT>TBT,TET>TMT, paralleling that found in other isolated cell cultures
exposed to these organotins. However this order does not correlate with the reported
regional specificity of these compounds as neurotoxicants. This lack of cytotoxicity by
TMT in astrocytes does not rule out non-lethal, region specific changes in cell function
that could disrupt the normal CNS environment and cause neurotoxicity.

Chapter 2; Organotins Disrupt Components of Glutamate Homeostasis
in Rat Astrocyte Cultures
Abstract
The effects o f subtoxic concentrations of three organotins on two key components
of glutamate homeostasis in astrocytes were investigated. Appropriate subtoxic
concentrations were determined for trimethyltin (TMT), triethyltin (TET), and
triphenyltin (TPT) by measuring lactate dehydrogenase (LDH) release. A second cell
viability assay measuring mitochondrial activity confirmed the relative non-toxic effects
o f these concentrations. Astrocytes were exposed to 1 pM or 5 pM TMT, 1 pM TET,
and 1 pM TPT for 24-72 hours. Glutamine synthetase (OS) activity was measured in
treated cells. All three organotins decreased OS activity. Control experiments showed
that the organotins did not affect purified sheep brain OS or cell lysates after acute
exposure. Glutamate transport activity was determined in astrocytes exposed to 1 pM
TMT, 1 pM TET, and 1 pM TPT. TET decreased transport at all three exposure times.
TPT decreased glutamate uptake after 24 hours, but the decrease recovered to control
levels by 48 hours. TMT did not affect glutamate transport. None of the organotins
altered uptake activity after acute exposure. Both TMT and TPT decreased GS without
chronically disrupting glutamate transport. TET decreased both components of astrocytic
glutamate homeostasis. The effects of organotins on astrocytic glutamate homeostasis do
not explain the in vivo pathology or regional specificity of CNS cell damage that follows
organotin exposure.
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Introduction
Organotins are synthetic products commonly used in industry and agriculture as
plastic stabilizers, molluscicides, insecticides and fungicides (Nicklin and Robson, 1988).
The triorganotins are the most toxic of the organotins to mammals. Small changes in
chemical structure drastically alter their spectrum of toxicity (Nicklin and Robson, 1988).
Trimethyltin (TMT) and triethyltin (TET) have been shown to cause neurological deficits
in humans and animals (McMillan and Wenger, 1985). TMT causes a delayed
neurotoxicity that is characterized by damage to the hippocampal region (Brown et a l,
1979) and causes a dose-dependent decrease in serotonin, norepinephrine, and GAB A
levels in different specific regions of the limbic system (Earley et a l, 1992). TET causes
cerebral edema, primarily affecting white matter (McMillan and Wenger, 1985).
Triphenyltin (TPT) causes cell damage in the thymus, kidney and liver (Nicklin and
Robson, 1988). Although not known as neurotoxic, a case study of acute TPT exposure
reported transient ataxia, confusion, and visual disturbances (Wu et a l, 1990).
Glutamate is an excitatory neurotransmitter found throughout the CNS
(Monaghan et a l, 1989). Elevated levels of endogenous glutamate can overstimulate
receptors and cause neuronal damage. This phenomenon is referred to as excitotoxicity
(Rothman and Olney, 1987). A brief five minute, exposure to 50-100 pM concentrations
o f extracellular glutamate in vitro causes cell death to neurons, but not glial cells (Choi et
a l, 1987). Investigators have shown evidence for TMT induced increases in glutamate
release in partially depolarized hippocampal slice preparations (Patel et a l, 1990) and in
cortical slices (Dawson et a l, 1995). TMT does not have excitotoxic actions itself, but
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produces a pattern of damage similar to the glutamate agonist, kainic acid (Dyer et al,
1982). A 30 minute preincubation with 50 pM TMT caused a decrease in sodium
dependent glutamate uptake in astrocytes (Aschner et a l, 1992) and 15 minute
preincubation with 50 pM TMT decreased glutamate uptake in synaptosomal
preparations (Naalsund and Fonnum, 1986). A model of slow neurotoxicity developing
over several weeks has been proposed after inhibition of glutamate uptake in organotypic
spinal cord cultures (Rothstein et al, 1993). This model is in contrast to the rapid
neurotoxicity produced minutes after increased concentrations of extracellular glutamate
occur in the CNS (Rothman and Olney, 1987). Decreased glutamate uptake by TMT
could cause an increase in extracellular glutamate that might initiate an excitotoxic event
or slow neurotoxicity. It is not known whether TET or TPT interferes with the
glutamatergic system in the CNS.
Astrocytes play a critical role in maintaining glutamate homeostasis. Reducing
the number of astrocytes present in a neuronal culture increases neuronal sensitivity to
extracellular glutamate (Rosenberg and Aizenman, 1989). Astrocytes have at least two
specific glutamate transporters (GLAST, GLTl) which play a role in removing excess
glutamate from extracellular space (Rothstein et a l, 1996). The enzyme glutamine
synthetase (EC 6.3.1.2) is also localized in astrocytes and detoxifies glutamate by
converting it to the less excitotoxic amino acid glutamine (Farinelli and Nicklas, 1992).
Both astrocytic glutamate transport and glutamine synthetase (GS) are important factors
in the maintenance of extracellular glutamate levels and prevention of excitotoxicity.
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The evidence of TMT involvement in the glutamatergic system in the CNS
prompted our investigation of the effect of three organotins on glutamate homeostasis.
The purpose of this investigation was to determine the effects of subtoxic concentrations
o f the organotins on GS activity and glutamate transport in astrocytes. TMT exposure
should show a specific effect on astrocyte function if disruption of glutamate homeostasis
contributes to the selective toxicity o f this neurotoxic organotin. Disruption of astrocyte
function could offer a partial explanation of changes observed in CNS pathology after in
vivo exposure to TMT. Our study compared the effects of TMT and TET, two neurotoxic
organotins with differing regional specificity, and TPT, a non-neurotoxic organotin. We
found that subtoxic concentrations of TMT, TET and TPT decreased GS activity, but
only TET chronically decreased glutamate transport.

Methods

Materials:
Pregnant female Sprague-Dawley rats were obtained from Simonsen Labs
(Gilroy, CA). Rats were maintained on a 12 hr light-dark cycle with food and water ad
libitum. Cell culture media was purchased from Gibco-BRL (Grand Island, NY) and
fetal calf serum (PCS) from Hyclone (Logan, UT). All cell culture plasticware was
obtained from Fisher Scientific (Santa Clara, CA). All chemicals and sheep brain GS
were purchased from Sigma (St. Louis, MO), except trimethyltin chloride, triethyltin
chloride, and triphenyltin chloride (Aldrich, Milwaukee, WI).
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Cell Culture:
Primary cultures of type I astrocytes were prepared from 4 day old rat pups as
described by McCarthy and de Vellis (1980). Cortical hemispheres were dissected free,
meninges and subcortical structures removed. After disruption of the cortical tissue by
trituration, the cells were plated in a 1:1 mixture of Dulbecco’s Modification o f Eagle’s
Medium and Ham’s F12 medium. Media was supplemented by addition of 15 mM
HEPES, 1.2 g/L of sodium bicarbonate, penicillin (100 units/ml), streptomycin (100
pg/ml), and Fungizone (0.1 pg/ml), and adjusted to pH 7.4. The cells were cultured in
poly-D-lysine coated 80 cm" flasks maintained at 37° C in a humid atmosphere containing
5% COj. The medium was supplemented with 15% FCS (vol/vol) during the initial
plating and then maintained with 10% FCS (vol/vol).
When 60-70% confluent, the cells were shaken in fresh media on a Hi-Line orbital
shaker (280 rpm, 24 hr) to remove oligodendrocytes, type II astrocytes, and microglia.
Two or three days later the astrocytes were harvested by trypsinization and plated into
uncoated Falcon 12 well plates at a density of 10^ cells/ml. These secondary cultures
were maintained in a similar environment with media changes every 3-4 days and
allowed to reach confluence (14-21 days). Homogeneity of astrocyte cultures was
monitored by microscopic observation and by the presence of the astrocytic marker
GFAP. Cultures were found to be > 95% GFAP (+).
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Organotin Treatments:
TMT and TET were dissolved in distilled, deionized HjO, filter sterilized, and
introduced into the media to achieve the appropriate concentrations. TPT was dissolved
in 100% DMSO, diluted into media, sterile filtered, and further diluted in media to
appropriate concentrations. DMSO did not exceed 0.1% (vol/vol) in final dilution. This
solvent concentration did not cause increased LDH release.

Lactate Dehydrogenase (LDH):
Cell death was estimated by measuring the extent of lactate dehydrogenase (LDH)
leakage into the culture medium (Vassault, 1983; Koh and Choi, 1987). Extracellular
fluid was aspirated and cells were lysed with 0.1% (vol/vol) Triton-X in serum-free
culture media. LDH activity was determined in the media and the cell lysate fraction by
measuring the rate o f disappearance of NADH from the reaction mixture (AOD3 4 0 ) using a
Molecular Devices 96 well plate reader and SOFTmax PRO software. Percent
extracellular LDH was calculated using the formula: % extracellular LDH = 100 x
[(extracellular AOD/min) -r (extracellular + intracellular AOD/min)].

M TT Reduction:
A second cell viability assay was used measuring the reduction of a water soluble
tétrazolium salt to formazan by the method of Slater (1963), modified by Mossman
(1983). Briefly, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tétrazolium bromide (MTT)
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was dissolved in distilled, deionized H 2 O at 5 mg/ml and further diluted to a working
solution 1; 10 in Kreb’s Ringer Buffer (KRB). Extracellular media was aspirated from 12
well plates. Two-hundred microliters of the MTT working solution, and 300 pi KRB was
added to each well. Cells were incubated for 3 hr in a 37° C incubator to allow time for
the reduction reaction. After 3 hr, 1.5 ml of 0.1 M HCl in isopropanol was added to the
wells to solubilize the purple formazan crystals. Sealed well-plates were refrigerated
overnight, and read on a Beckman DU450 spectrophotometer at 560 nm. Results were
reported as a percent of the optical density produced by control wells from the same
culture plate.

Glutamine Synthetase Assay:
Enzyme activity was determined by the colorimetric method of Meister (1985).
Media was removed and astrocytes were rinsed with phosphate buffered saline. Cells
were lysed with 1.1 ml of hypotonic buffer (10 mM imidizole-HCl, 0.5 mM EDTA, pH
7.0). A 750 pi aliquot o f the lysate was added to 750 pi of reaction mixture containing:
0.25 M L-glutamine, 1.25 M hydroxy lamine, 4 mM manganese chloride, 200 mM arsenic
acid, and 8 mM ADP. The samples were incubated for 60 minutes at 37° C. The reaction
was rapidly halted in an ice bath with addition of 1.5 ml of acidic ferric chloride (0.37 M
FeClg, 0.67 M HCl, and 0.2 M trichloroacetic acid). After allowing 30 min for color
development, samples were centrifuged and read on a Beckmein DU650
spectrophotometer at 555 nm. Values of y-glutamyl hydroxamate (yGH) produced per
minute per milligram of protein were determined by comparison with a standard curve
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developed from a range o f yGH concentrations. Values were reported as % control (yGH
production in untreated cells). Additional experiments using purified sheep brain GS or
astrocyte lysates were performed. These preparations were exposed to organotins for 60
minutes to determine acute effects.

Glutamate Transport Assay:
Effects of organotins on glutamate transport by astrocytes was determined by
measuring ^H-D-aspartate uptake (Wolpaw and Martin, 1984). Cell's were rinsed tliree
times with HEPES Buffered Hank’s Balanced Salt (HBHS) solution (53 mM KCl, 4.4
mM KH 2 PO 4 , 136 mM NaCl, 6.5 mM Na2 HP 0 4 , 55 mM D-glucose, 1.1 mM CaCl2 , 0.71
mM MgS 0 4 , 5.5 mM D-glucose, 10 mM HEPES). Cells were allowed to equilibrate to
30° C for 10 min in HBHS. The buffer was replaced with pre-warmed 50 pM ^H-Daspartate (0.056 mC/pmol) in HBHS for 5 min. The media was rapidly aspirated and
rinsed three times with ice cold HBHS to remove extracellular ^H-D-aspartate. Cells
were lysed overnight with 1 ml 0.4 M NaOH. 200 pi of sample was added to 1.5 ml
liquid scintillation fluid and counted for 10 min on a Beckman LS 6500 liquid
scintillation counter. The acute effects of organotins on glutamate transport were also
determined by exposing astrocytes to TMT, TET, or TPT for 5 min while incubating with
50 pM ^H-D-aspartate. Values were reported as the rate of D-aspartate transport/min/mg
protein.
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Protein Determinations:
Protein determinations for the GS and glutamate transport assays were measured
by the method of Bradford (1976).

Statistics:
The LDH, MTT, GS, and glutamate transport experiments were repeated with
different culture preparations with n =

6

to

2 0

for each concentration and time point.

Descriptive statistics, ANOVA, and Tukey’s multiple comparison test were determined
with the GBSTAT® software program.

Results
Astrocytes were exposed to concentrations of 1-10 pM TMT, TET, and TPT for
24 to 72 hr (Fig. 1). Figure 1A shows the effect of three concentrations of TMT on
astrocyte viability. Clearly, the IpM and 5 pM concentrations were not toxic, while 10
pM TMT produced a delayed cytotoxicity after 72 hr. Figure IB shows that the astrocyte
cultures were more sensitive to TET exposure with concentrations as low as 2.5 pM
producing significant cytotoxicity after 24 hr exposure. A concentration of 1 pM TET
produced no discernible cytotoxicity. TPT produced almost 100% cell death in
concentrations as low as 2.5 pM (Fig. 1C). After 72 hr, 1 pM TPT caused a small
increase in extracellular LDH (19.4±6.2%).
Figure 2 shows that a 1 pM concentration of TMT and TET did not alter MTT
reduction to formazan. Exposure to 1 pM TPT produced a significant increase in
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formazan production after 72 hr. This was the same time and concentration at which
increased LDH release occurred.
The effect of subtoxic concentrations of organotins on the activity of GS was
investigated. GS activity in unexposed cells ranged from 1-5 nmol/min/mg protein. The
variation in control values is due to differences between culture preparations. Variation
in sister cultures from the same preparation did not exceed 15%. These values are similar
to those of 1-4 nmol/min/mg protein reported by others in rat astrocytes (Wu et a i, 1988;
Collins et a i, 1994). Figure 3 presents data that shows there was no change in GS
activity when cell homogenates were acutely exposed to the organotins and that there was
no direct effect on purified sheep brain GS. Figure 4 shows that 1 pM TET and 1 pM
TPT exposure decreased GS activity after 24 and up to 72 hr. GS activity was not
decreased by IpM TMT, while 5 pM TMT exposure decreased GS activity by 30% after
48 hr.
Interaction of organotins with astrocytic glutamate transport was measured by
quantifying the uptake of ^H-D-aspartate. Our control values of 2-2.5 nmol/min/mg
protein were comparable to other reported transport rates of

1 - 2

nmol/min/mg protein in

rat astrocytes (Bender et al., 1997; Miyazaki et al, 1997). In our study, none of the
organotins affected transport activity with acute exposure at subtoxic concentrations (Fig.
5). Figure

6

shows that 1 pM TET decreased D-aspartate transport activity in astrocytes

at all three exposure times. A 30% decrease in D-aspartate transport
activity was seen after 24 hr exposure to 1 pM TPT. The decreased transport activity
after TPT exposure recovered to control levels after 48 hr. 1 pM TMT did not affect D-

38

aspartate uptake. Additional experiments showed that increasing TMT concentrations to
25 pM (data not shown), a concentration well above the cytotoxic threshold, did not
affect glutamate transport.
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Figure 1 : Primary astrocytes were exposed to 1 - 1 0 juM organotins for 24-72 hours and
LDH release was determined. For each data point, n = 6 to 26. (A) TMT exposure, (B)
TET exposure, (C) TPT exposure. ** Significantly different from control, (p < 0.01).
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Figure 1: Primary astrocytes were exposed to 1- 10 pM organotins for 24-72 hours and
LDH release was determined. For each data point, n = 6 to 26. (A) TMT exposure, (B)
TET exposure, (C) TPT exposure. ** Significantly different from control, (p < 0.01).
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Discussion
The effects of the three organotins on astrocyte viability were measured by LDH
release. This data was used to determine the subtoxic concentrations needed to
investigate the effects of organotins on glutamate homeostasis. The results from Figure 1
show that 1 |aM TMT, 5 p.M TMT and 1 p.M TET did not produce increases in LDH
release in our astrocyte culture system. TPT at 1 pM was close to the cytotoxic
threshold, not producing cytotoxicity until after 72 hr exposure. Based on the data in
Figure 1, we chose to investigate the effects of these concentrations of organotins on two
specific astrocyte functions involved in glutamate homeostasis.
GS activity was decreased after chronic exposure to 5 pM TMT, 1 pM TET and 1
pM TPT. TMT, TET, and TPT do not inhibit GS directly as shown by a lack of
inhibition of both sheep brain GS and GS activity in acutely exposed cell lysates. It is
possible that organotins produce reactive oxygen species (ROS) that inactivate GS.
Purified sheep brain GS is inactivated by oxygen radicals produced by 6 -hydroxydopamine and enzyme activity is preserved by addition of superoxide dismutase (Schor,
1988). Concentrations of TPT between 1 and 3 pM cause mitochondrial and intracellular
calcium release within five minutes (Zazueta et a l, 1994; Viviani et al, 1995). This
calcium release could initiate any of a number of destructive biochemical cascades. One
possibility is that oxygen radicals are generated after TPT induced calcium movement.
Figure 2 shows that after chronic exposure to IpM TPT, mitochondrial activity is
increased. Decreases in GS activity are seen before the increase in mitochondrial activity.
The timing of these results suggests that GS inhibition is not a consequence of increased
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mitochondrial activity. Another possibility is that GS activity is affected by lower
concentrations of ROS, generated prior to detectable changes in mitochondrial activity.
The rapid calcium movement is not seen after TMT or TET exposure (Viviani et al,
1995), indicating that the consequences of increased intracellular calcium are unlikely to
be a common mechanism for organotin inhibition of GS. The inhibition of GS by 5 pM
TMT is delayed until 48 hr after exposure (Fig. 4), correlating with the delayed
cytotoxicity seen at higher concentrations (Fig. 1A). It is not clear why the TMT effect is
delayed, but the extent of GS inhibition is essentially the same for all three organotins.
TET (1-100 pM) inhibits taurine transport in a glioma cell line without prolonged
pre-incubation periods (Martin et a l, 1983). The same study found the IC5 0 for TET
inhibition o f glutamate transport after acute exposure to be > 100 pM. Our experiments
with 1pM concentrations showed that none of the organotins had an effect on the
transporter after acute exposure. We saw an inhibition of glial glutamate transport by
TET and TPT after 24 hr exposure. Loss of glutamate transport has not been implicated
in gliotoxicity, but can increase the extracellular concentration of glutamate, triggering
the neurodegeneration characteristic of excitotoxicity (Rothstein et al., 1996). Astrocytes
exposed to 1 pM TET up to 72 hr maintain a decreased rate of glutamate uptake. TPT
caused an initial decrease in glutamate transport, but in contrast to TET, the astrocytes
seemed to recover transport activity after extended exposure (48 and 72 hr).
The combination of decreased GS and decreased transport after TET exposure
could rapidly increase extracellular glutamate levels in the brain, triggering an excitotoxic
event. These alterations in key astrocytic components of glutamate homeostasis could
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contribute to the cellular damage in CNS tissue caused by a prolonged glutamate
challenge. It has been shown that a 50% inhibition of GS by methionine sulfoxlmine
(MSO) increases glial glutamate uptake by 93% (Rothstein and Tabakoff, 1985). In our
study, a 30-50% inhibition of GS after TET exposure accompanied a 50-60% decrease in
transport. The lack of a similar transporter response after GS inhibition produced by
TET suggests that this organotin is not affecting glutamate homeostasis the same way as
the GS inhibitor MSO. TET actually decreased both GS and transport activity. This TET
effect might be expected as a result of changes in the glutamate concentration gradient
within a GS compromised astrocyte.
In contrast to TET, TMT produced a delayed decrease in GS activity without
affecting glutamate uptake. TMT has been shown to decrease glutamate uptake in
synaptosomal preparations at concentrations of 0.05-5 mM (Naalsund and Fonnum,
1986). However, these concentrations are highly toxic in most in vitro systems
(Thompson et a l, 1995) and 10 to 100 fold higher than the subtoxic concentrations used
in our experiments. Even though a subtoxic concentration of TMT decreases GS activity
(Fig. 4), in our laboratory only toxic concentrations of lOOpM and higher decrease both
mechanisms of astrocyte glutamate homeostasis. It is unlikely that disruption of
glutamate uptake can completely account for TMT neurotoxicity. TMT concentrations
that are gliotoxic also decrease glutamate transport. A decrease in transport could
increase extracellular concentrations of glutamate and possibly initiate excitotoxicity.
However, a TC 5 0 of 0.0IpM TMT has been reported in cortical neurons (Thompson et a l,
1996). The TMT concentration required to cause neuronal damage is much lower than
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that reported to decrease glutamate transport. Therefore, TMT inhibition of glutamate
transport probably does not contribute to its mechanism of neurotoxicity. The reported in
vivo pathology after TMT exposure also indicates neuronal cell death without loss of
astrocytes (Brock and O'Callaghan, 1987). TMT does decrease GS activity at
concentrations that do not cause cytotoxicity without changes in glutamate transport.
This may allow for a slower accumulation of extracellular glutamate leading to the
delayed toxicity observed in in vivo models.
TPT exposure also decreased GS activity up to 72 hr (Fig. 4) and glutamate
transport only after 24 hr (Fig. 6 ). TPT at 1 pM did not produce cytotoxicity prior to 72
hr. TPT does decrease glutamate transport activity after 24 hr exposure without evidence
of cytotoxicity, but there are no sustained chronic effects. Effects of TPT on glutamate
homeostasis preceded changes in LDH release and formazan production. These changes
in cytotoxicity and mitochondrial activity did not appear to alter the effects of TPT on GS
or glutamate transport, implying that the inhibition of GS and glutamate transport are not
consequences of cell death.
In conclusion, three organotins with different specific in vivo toxicity all alter
components of glutamate homeostasis. The unique neuropathology exhibited by TMT is
not reflected in its actions on astrocytic components of glutamate homeostasis. In fact,
TPT, a non-neurotoxic organotin, inhibits GS to a similar extent and also does not
chronically inhibit glutamate transport. Only TET decreases both GS and glutamate
transport activity. Inhibition of the two key astrocytic components of glutamate
homeostasis may account for part of the neurotoxic action of TET. Regional distribution
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o f GS and glutamate transport could account for differences between TMT and TET
neurotoxic specificity.
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Conclusions:
1. The relative potency of the organotins in primary astrocyte culture was TPT > TBT,
TET > TMT. TMT cytotoxicity was only apparent after 48 hours and at a concentration
of 100 pM. The other three organotins TET, TBT and TPT produced cytotoxicity as
early as 24 hours after 2.5 pM exposure.
2. TET, TBT and TPT produced different morphological changes than TMT. These
observed morphological changes coincided with cytotoxicity measured by LDH release.
3. After 24 hour exposure, TMT and TET produced an increase in mitochondrial activity.
This increase in metabolic activity preceded cell death. TBT and TPT decreased
mitochondrial activity.
4. Chronic exposure to TMT, TPT, and TET decreased GS activity. Only TET decreased
activity in both astrocytic components of glutamate homeostasis at a subtoxic
concentration. This effect on glutamate homeostasis may contribute to the observed in
vivo neurotoxicity of TET.
5. The order of effectiveness of cytotoxicity and interaction of organotins with
components o f glutamate homeostasis in astrocyte culture does not correlate with the
reported in vivo pathology. Regional distribution of GS and glial glutamate transporters
could contribute to differences in the regional specificity of neurotoxicity after TMT and
TET exposure.
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